Europe Diabetes Care Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - Request a Free Sample

Europe Diabetes Care Devices Market Overview

Diabetes care devices are advancing through the adoption of connected technologies that improve monitoring accuracy and treatment effectiveness. These innovations support better disease management and enhance quality of care. The market is fueled by favorable healthcare policies, increasing investment in medical technology, rising chronic disease burden, and growing acceptance of smart diabetes management solutions. The market is poised to reach USD 30.38 Billion by 2035. The market is expected to grow steadily during the forecast period, supported by ongoing technological advancements and increasing adoption of diabetes care devices.

Europe Diabetes Care Devices Market Growth Analysis and Key Influencers

Europe Diabetes Care Devices Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Europe Diabetes Care Devices Market Growth Drivers

Advanced Continuous Glucose Monitoring Technologies Accelerate the Market Value

The increasing adoption of advanced continuous glucose monitoring (CGM) technologies is strengthening the market by improving diabetes management, supporting real-time glucose tracking, and enhancing patient outcomes across Europe. For instance, in December 2024, A. Menarini Diagnostics entered an exclusive distribution agreement with Sinocare to commercialize its third-generation CGM system across more than 20 European jurisdictions, significantly expanding access to advanced glucose monitoring solutions. This growing availability of innovative diabetes technologies is expected to support long-term market expansion and encourage wider device adoption.

Europe Diabetes Care Devices Market Restraints

Device Safety and Performance Concerns Limit the Market Expansion

Concerns regarding the safety, reliability, and performance of diabetes management devices continue to challenge the market by affecting user confidence and increasing regulatory scrutiny. For instance, in November 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) encouraged users to report safety issues involving continuous glucose monitoring devices and insulin pumps after identifying concerns related to device accuracy, connectivity, and physical failures. Such challenges may slow product adoption and increase compliance requirements, limiting overall market growth.

Europe Diabetes Care Devices Market Opportunities

Expansion of Advanced Insulin Delivery Technologies Creates New Market Potential

The growing introduction of advanced automated insulin delivery systems across Europe is creating significant potential for the market by improving treatment convenience and expanding patient access to innovative diabetes care. For example, in July 2026, Medtrum announced progress toward launching its 300-unit tubeless patch pump in Germany, supported by reimbursement listing and continued expansion of its integrated TouchCare Nano System. Such advancements are expected to strengthen technology adoption and support sustained market development.

Europe Diabetes Care Devices Market Trends

The market is witnessing several trends, including automated insulin delivery, connected diabetes care, and wearable glucose monitoring technologies.

Growing Adoption of Automated Insulin Delivery Systems is Expected to Enhance the Market Growth

The increasing preference for automated insulin delivery systems is transforming diabetes management by improving glucose control and reducing the daily treatment burden. For instance, in June 2023, Insulet commercially launched the Omnipod® 5 Automated Insulin Delivery System in the United Kingdom, expanding access to tubeless hybrid closed-loop technology for individuals with type 1 diabetes. Such advancements are expected to accelerate innovation and contribute to sustained market growth.

Europe Diabetes Care Devices Market Share

Insulin Delivery Devices are Expected to Lead the Market

The market is segmented into blood glucose monitoring systems, insulin delivery devices, diabetes management mobile applications. Among these, insulin delivery devices are expected to hold the leading share owing to continuous product innovation, improved patient comfort, and increasing demand for convenient insulin administration. For instance, in August 2025, Trividia Health UK launched TRUEplus 5-Bevel Pen Needles in the United Kingdom, offering cost-effective and more comfortable insulin delivery options. Such innovations are anticipated to strengthen the adoption of insulin delivery devices across the market.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

Europe Diabetes Care Devices Market Analysis by Region

The regions covered in the report include the United Kingdom, Germany, France, Italy, Spain, and Others. Among these, the United Kingdom is expected to lead the market due to strong research investments, increasing innovation in diabetes diagnostics, and a well-established healthcare infrastructure. For instance, in February 2025, Lancaster University received funding to develop a rapid electrochemical sensor for measuring C-peptide levels, enabling faster assessment of insulin production and supporting personalized diabetes care. Such research initiatives are expected to reinforce the country's leadership in the market.

Leading Players in the Europe Diabetes Care Devices Market

Europe Diabetes Care Devices Market Segmentation

Key Questions Answered in the Europe Diabetes Care Devices Market Report

• What was the Europe diabetes care devices market value in 2025?
• What is the Europe diabetes care devices market forecast outlook for 2026-2035?
• What are the major factors aiding the Europe diabetes care devices market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major diabetes care devices market trends?
• Which product type is expected to dominate the market segment?
• Which disease type is projected to lead the market segment?
• Which patient care setting is anticipated to drive the market segment?
• Who are the key players involved in the Europe diabetes care devices market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed using a comprehensive mixed-methods research approach that integrates primary and secondary research with rigorous data validation:

• Primary Research: In-depth interviews conducted with 30+ endocrinologists, diabetologists, diabetes specialist nurses, hospital procurement managers, medical device distributors, and reimbursement experts across the United Kingdom, Germany, France, Italy, and Spain, including key opinion leaders (KOLs) from leading diabetes centers and professional associations.
• Secondary Research: Peer-reviewed publications from Diabetes Care, Diabetologia, The Lancet Diabetes & Endocrinology, BMJ, regulatory guidance from the European Medicines Agency (EMA), Medicines and Healthcare products Regulatory Agency (MHRA), European Commission, epidemiological data from the World Health Organization (WHO) and International Diabetes Federation (IDF), clinical trial databases, company annual reports, investor presentations, product catalogs, press releases, and official company websites of leading diabetes care device manufacturers.
• Validation: All market estimates are triangulated using top-down and bottom-up market modeling, followed by multiple expert review cycles to ensure the accuracy, consistency, and reliability of the findings.